US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

NuStar Logistics 7.625% Fixed To Floating Rate Subordinated Notes

25.44

+0.0000

Volume:- -

Turnover:- -

Market Cap:2.00B

PE:17.90

High:25.44

Open:25.44

Low:25.44

Close:25.44

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Press Release: Centessa Pharmaceuticals Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2024

Revolutionary ARM Chip Deal: Malaysia’s $250M Masterplan to Dominate AI Semiconductor Manufacturing

Amentum Secures COSMIC Contract to Enhance NASA's Space Infrastructure

Centessa Pharmaceuticals Reports Financial Results for the Third Quarter of 2024 and Provides Business Update

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/NSS"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NSS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NSS\",,,,,undefined,":{"symbol":"NSS","market":"US","secType":"STK","nameCN":"NuStar Logistics 7.625% Fixed To Floating Rate Subordinated Notes","latestPrice":25.44,"timestamp":1745524800000,"preClose":25.44,"halted":0,"volume":0,"delay":0,"floatShares":0,"shares":78616228,"eps":1.421537,"marketStatus":"Post-Mkt","change":0,"latestTime":"04-24 16:56:00 EDT","open":25.44,"high":25.44,"low":25.44,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":1.421537,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1745539200000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":25.44,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NSS\",,,,,undefined,":{"symbol":"NSS","floatShares":0,"roa":"2.45%","roe":"3.39%","lyrEps":1.421537,"shares":78616228,"dividePrice":3.1174,"high":25.44,"amplitude":0,"preClose":25.44,"low":25.44,"week52Low":25.12,"pbRate":"1.07","week52High":27.4726,"institutionHeld":0,"latestPrice":25.44,"eps":1.421537,"divideRate":0.122539,"volume":0,"delay":0,"ttmEps":1.421537,"open":25.44,"prevYearClose":25.88},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/NSS\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NSS\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2521745072","title":"Press Release: Centessa Pharmaceuticals Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2521745072","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521745072?lang=en_us&edition=fundamental","pubTime":"2025-03-24 19:00","pubTimestamp":1742814000,"startTime":"0","endTime":"0","summary":"Centessa Pharmaceuticals Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2024. -- Advancing a broad, potential best-in-class orexin receptor 2 . agonist franchise with key data readouts expected in 2025. -- ORX750 Phase 2a CRYSTAL-1 study for the treatment of narcolepsy. type 1 , narcolepsy type 2  and idiopathic hypersomnia.  well underway and on track with data expected across all. three indications in 2025 with first-in-class potential in NT2 and. Dr. Saha concluded, \"In addition to the transformational potential of ORX750 for individuals living with sleep-wake disorders, we see tremendous opportunity with our follow-up OX2R agonists that are being advanced for the treatment of EDS, impaired attention, cognitive deficits and fatigue in neurological, neurodegenerative and neuropsychiatric disorders. ORX142 is prog","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4563","BK4539","BK4218","BK4139","BK4535","BK4178","AAN","NSS","CNTA","BK4215","BK4232","ESS","BK4510","IH","BK4181","PK","MSL","BK4597","R","BK4022","BK4085","BK4588"],"gpt_icon":0},{"id":"2517912460","title":"Revolutionary ARM Chip Deal: Malaysia’s $250M Masterplan to Dominate AI Semiconductor Manufacturing","url":"https://stock-news.laohu8.com/highlight/detail?id=2517912460","media":"CoinMarketCap","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517912460?lang=en_us&edition=fundamental","pubTime":"2025-03-05 21:49","pubTimestamp":1741182563,"startTime":"0","endTime":"0","summary":"In a revolutionary move that’s sending ripples through the global tech landscape, Malaysia is solidifying its position as a rising star in semiconductor manufacturing. As tensions simmer between tech giants like the U.S. and China, particularly concerning AI-driven technologies, the spotlight has shifted towards nations offering neutral ground and burgeoning tech ecosystems. Enter Malaysia, poised to capitalize on this global realignment, and now, sealing a game-changing ARM chip deal Malaysia.SoftBank-backed ARM Holdings, a titan in chip design, has officially inked a significant agreement with the Malaysian government. This isn’t just another business deal; it’s a strategic alliance aimed at supercharging Malaysia’s chip design capabilities. But what does this entail, and why is it such a big deal?Massive Investment: Malaysia is committing a substantial $250 million over the next decade to ARM.Technology Transfer: This investment isn’t just about money; it’s about acquiring cutting-e","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://coinmarketcap.com/community/articles/67c85664379dd72f3cb3b3e5/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"coinmarketcap_highlight","symbols":["BK4515","LU0348723411.USD","LU0321505439.SGD","BK4579","BK4602","IP","BK4527","BK4534","IE00BMPRXN33.USD","BK4529","IE00BMPRXQ63.HKD","BK4512","BK4588","LU0321505868.SGD","BK4575","LU1481600234.SGD","BK4543","LU1487256676.USD","BK4605","BK4609","LU0081259029.USD","IE00BMPRXR70.SGD","BK4585","BK4533","NSS","BK4136","BK4141","BK4554","ARM","BK4535","BK4550","LU1481599808.USD","LU2463526074.USD"],"gpt_icon":1},{"id":"2509627693","title":"Amentum Secures COSMIC Contract to Enhance NASA's Space Infrastructure","url":"https://stock-news.laohu8.com/highlight/detail?id=2509627693","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509627693?lang=en_us&edition=fundamental","pubTime":"2025-02-06 21:15","pubTimestamp":1738847700,"startTime":"0","endTime":"0","summary":"CHANTILLY, Va., February 06, 2025----Amentum , in collaboration with Chugach Government Solutions  through the Nova Space Solutions  Joint Venture, has been awarded NASA’s Consolidated Operations, Services, and Maintenance Infrastructure Contract  at Stennis Space Center  and Michoud Assembly Facility . On COSMIC, Amentum will deliver advanced technologies to elevate operational innovation for our national space infrastructure.With a contract value of $822.7 million, the COSMIC contract is scheduled to start operations in July 2025 and extend over 8 years. As part of this project, NSS will deliver essential facility solutions, engineering and manufacturing capabilities, contract management, logistics, facility operations, and environmental solutions.\"Amentum brings technical agility and intelligent infrastructure leadership to our long-standing partnership with NASA,\" said Mark Walter, President of Amentum Engineering & Technology Group. \"By delivering innovative solutions like Intelli","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/amentum-secures-cosmic-contract-enhance-131500667.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4123","NSS","AMTM"],"gpt_icon":0},{"id":"2482703353","title":"Centessa Pharmaceuticals Reports Financial Results for the Third Quarter of 2024 and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2482703353","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482703353?lang=en_us&edition=fundamental","pubTime":"2024-11-12 20:00","pubTimestamp":1731412800,"startTime":"0","endTime":"0","summary":"Announced additional interim data from ongoing Phase 1 clinical study of ORX750, a novel orexin receptor 2 (OX2R) agonist, in acutely sleep-deprived healthy volunteers that further support best-in-cla","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/12/2978926/0/en/Centessa-Pharmaceuticals-Reports-Financial-Results-for-the-Third-Quarter-of-2024-and-Provides-Business-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ECG","01698","BK4510","LU0359202008.SGD","BK4181","IE00BYTNYN87.SGD","SG9999011746.SGD","LU0359201612.USD","IH","IE00BYQNZ168.SGD","IE00B12V2V27.USD","BK4218","BK4215","BK4563","LU1023057109.AUD","BK4535","BK4548","LU2039709279.SGD","BK4552","BK4571","BK4526","BK4588","BK4129","ESS","NSS","BK4085","BK4108","BK4565","BK4585","BK4531","PK","TME","BK4509"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":4,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NSS\",params:#limit:5,,,undefined,":[{"date":"2024-07-01","symbol":"NSS","amount":0.77882,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-07-01","name":"NuStar Logistics L.P. 7.625% Fi","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-15","payableDate":"2024-07-01","currency":"USD","dateTimestamp":1719806400000,"payDate":"2024-07-15"},{"market":"US","date":"2024-06-03","symbol":"NSS","reason":null,"defaultRemindTime":1717421400000,"announcedDate":"2024-05-06","type":"delisting","dateTimestamp":1717387200000},{"date":"2024-03-28","symbol":"NSS","amount":0.7695,"announcedDate":null,"type":"dividend","market":"US","newRecordDate":"2024-04-01","defaultRemindTime":1711632600000,"name":"NuStar Logistics L.P. 7.625% Fi","recordDate":"2024-04-15","payableDate":"2024-04-01","currency":"USD","dateTimestamp":1711598400000,"payDate":"2024-04-15"},{"date":"2023-12-28","symbol":"NSS","amount":0.791549981,"announcedDate":null,"type":"dividend","market":"US","newRecordDate":"2023-12-29","defaultRemindTime":1703773800000,"name":"NuStar Logistics L.P. 7.625% Fi","recordDate":"2024-01-16","payableDate":"2023-12-29","currency":"USD","dateTimestamp":1703739600000,"payDate":"2024-01-16"},{"date":"2023-09-28","symbol":"NSS","amount":0.777517,"announcedDate":"2023-07-18","type":"dividend","market":"US","newRecordDate":"2023-09-29","defaultRemindTime":1695907800000,"name":"NuStar Logistics L.P. 7.625% Fi","recordDate":"2023-10-16","payableDate":"2023-09-29","currency":"USD","dateTimestamp":1695873600000,"payDate":"2023-10-16"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NSS\",market:\"US\",,,undefined,":[{"executeDate":"2017-03-29","recordDate":"2017-03-31","paymentDate":"2017-04-17","value":0.4765625,"currency":"USD"},{"executeDate":"2017-06-28","recordDate":"2017-06-30","paymentDate":"2017-07-17","value":0.4765625,"currency":"USD"},{"executeDate":"2017-09-28","recordDate":"2017-09-29","paymentDate":"2017-10-16","value":0.4765625,"currency":"USD"},{"executeDate":"2017-12-28","recordDate":"2017-12-29","paymentDate":"2018-01-16","value":0.4765625,"currency":"USD"},{"executeDate":"2018-03-28","recordDate":"2018-03-29","paymentDate":"2018-04-16","value":0.528387,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NSS\",market:\"US\",delay:false,,,undefined,":{}}}